NANOKNIFE SINGLE ELECTRODE PROBE, 15CM
Report
- Report Number
- 1319211-2011-00038
- Event Type
- Other
- Date Received
- May 19, 2011
- Date of Event
- June 30, 2010
- Report Date
- May 19, 2011
- Manufacturer
- ANGIODYNAMICS
- Product Code
- GEI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KY, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS REPORT IS NOT BEING SENT FOR A PRODUCT PROBLEM. THERE WAS NO INDICATION THAT THE DEVICE MALFUNCTIONED. THIS REPORT IS BEING SUBMITTED TO NOTIFY THE FDA THAT MEDICAL INTERVENTION WAS REQUIRED, IN THE FORM OF .5MG CARDENE IV (CA+ CHANNEL BLOCKER), DURING THE PROCEDURE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT FURTHER ISSUES. NO HARM OR INJURY WAS REPORTED TO THE PATIENT. THIS MEDWATCH IS BEING SUBMITTED LATE DUE TO A RETROSPECTIVE REVIEW OF CASE NOTES. (B)(4).
DURING A LAPAROTOMY WITH ULTRASOUND GUIDED NANOKNIFE ABLATION, THE PATIENT'S BLOOD PRESSURE AT BASELINE WAS APPROXIMATELY 120. WITHIN THE FIRST MINUTE OF PULSE GENERATION, THE PATIENT'S BLOOD PRESSURE BEGAN TO INCREASE, INDICATING HYPERTENSION. WHEN BLOOD PRESSURE WAS NOTED AT 190/114, THE PHYSICIAN ADVISED THAT PULSE GENERATION BE SUSPENDED. THE ANESTHESIOLOGIST GAVE 0.5MG CARDENE IV (CA+ CHANNEL BLOCKER) AND PATIENT'S BLOOD PRESSURE BEGAN TO NORMALIZE WITHIN 90 SECONDS OF ADMINISTRATION. WITH THE PATIENT'S BLOOD PRESSURE AT 112/63, THE PHYSICIAN ELECTED TO RESTART PULSE GENERATION. THE PATIENT'S BLOOD PRESSURE BEGAN TO INCREASE AGAIN INTO THE 150'S DURING PULSE GENERATION AND A SECOND DOSE OF CARDENE 0.5MG IV WAS ADMINISTERED. THE PATIENT'S BLOOD PRESSURE THEN REMAINED STABLE THROUGHOUT THE REST OF CASE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT FURTHER ISSUES. NO HARM OR INJURY WAS REPORTED TO THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | NANOKNIFE SINGLE ELECTRODE PROBE, 15CM | TISSUE ABLATION DEVICE | GEI | ANGIODYNAMICS | NA | NOT REPORTED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 70 YR | Required Intervention |